Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 45 articles: HTML format

Single Articles

October 2025
1. MCCANN N, Paganotti Vicentine M, Ebrahimi N, Greenland M, et al
   Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine.
   N Engl J Med. 2025;393:1704-1714.
   PubMed     Abstract available
   
   
   
2. SCOTT J, Abers MS, Marwah HK, McCann NC, et al
   Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026.
   N Engl J Med. 2025 Oct 29. doi: 10.1056/NEJMsa2514268.
   PubMed     Abstract available
   
   
   
3. CAI M, Xie Y, Al-Aly Z
   Association of 2024-2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans.
   N Engl J Med. 2025 Oct 8. doi: 10.1056/NEJMoa2510226.
   PubMed     Abstract available
   
   
   September 2025
4. NSANZIMANA S, Remera E, Nkeshimana M, Westergaard RP, et al
   Marburg Virus Disease in Rwanda, 2024 - Public Health and Clinical Responses.
   N Engl J Med. 2025;393:983-993.
   PubMed     Abstract available
   
   
   August 2025
5. JOHANSEN ND, Modin D, Loiacono MM, Harris RC, et al
   High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults.
   N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509907.
   PubMed     Abstract available
   
   
   
6. LASSEN MCH, Johansen ND, Christensen SH, Aliabadi N, et al
   RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults.
   N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509810.
   PubMed     Abstract available
   
   
   
7. PARDO-SECO J, Rodriguez-Tenreiro-Sanchez C, Gine-Vazquez I, Mallah N, et al
   High-Dose Influenza Vaccine to Reduce Hospitalizations.
   N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2509834.
   PubMed     Abstract available
   
   
   July 2025
8. CHU HY, Brewer NT, Asturias EJ, Brooks O, et al
   The Path Forward for Vaccine Policy in the United States.
   N Engl J Med. 2025 Jul 30. doi: 10.1056/NEJMsb2509134.
   PubMed    
   
   
   
9. PRASAD V, Makary MA
   An Evidence-Based Approach to Covid-19 Vaccination. Reply.
   N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa6. doi: 10.1056/NEJMc2507760.
   PubMed    
   
   
   
10. MEYEROWITZ EA
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa5. doi: 10.1056/NEJMc2507760.
    PubMed    
    
    
    
11. DREKONJA D
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa4. doi: 10.1056/NEJMc2507760.
    PubMed    
    
    
    
12. VOHRA-MILLER S, Marnik EA
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa3. doi: 10.1056/NEJMc2507760.
    PubMed    
    
    
    
13. HAIDAR G, Hauschildt KE, Michaels MG
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa2. doi: 10.1056/NEJMc2507760.
    PubMed    
    
    
    
14. PAPPAS G
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 Jul 9:10.1056/NEJMc2507760#sa1. doi: 10.1056/NEJMc2507760.
    PubMed    
    
    
    June 2025
15. MARKS P
    The Role of Public Health Agencies in Creating Vaccine Policy.
    N Engl J Med. 2025 Jun 25. doi: 10.1056/NEJMp2507404.
    PubMed    
    
    
    
16. SCHWARTZ JL
    Revised Recommendations for Covid-19 Vaccines - U.S. Vaccination Policy under Threat.
    N Engl J Med. 2025 Jun 18. doi: 10.1056/NEJMp2507766.
    PubMed    
    
    
    May 2025
17. PRASAD V, Makary MA
    An Evidence-Based Approach to Covid-19 Vaccination.
    N Engl J Med. 2025 May 20. doi: 10.1056/NEJMsb2506929.
    PubMed    
    
    
    
18. SCHMIDT AC, Fairlie L, Hellstrom E, Luabeya Kany Kany A, et al
    BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection.
    N Engl J Med. 2025;392:1789-1800.
    PubMed     Abstract available
    
    
    April 2025
19. JATT LP, Mgodi NM, Buchbinder SP, Gray GE, et al
    An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP - Essential or Irrelevant?
    N Engl J Med. 2025;392:1561-1563.
    PubMed    
    
    
    March 2025
20. YOUNG VB
    Vaccinating against Clostridioides difficile Infection.
    N Engl J Med. 2025;392:1237-1240.
    PubMed    
    
    
    February 2025
21. KIMATHI D, Juan-Giner A, Bob NS, Orindi B, et al
    Low-Dose Yellow Fever Vaccine in Adults in Africa.
    N Engl J Med. 2025;392:788-797.
    PubMed     Abstract available
    
    
    
22. WANG JJ, Warkentin TE, Schonborn L, Wheeler MB, et al
    VITT-like Monoclonal Gammopathy of Thrombotic Significance.
    N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMoa2415930.
    PubMed     Abstract available
    
    
    January 2025
23. HALL VG, Smibert OC, Sullivan SG, Lim C, et al
    Influenza Vaccination Strategies in Patients with Hematologic Cancer.
    N Engl J Med. 2025;392:306-308.
    PubMed    
    
    
    December 2024
24. MUYEMBE JJ, Pan H, Peto R, Diallo A, et al
    Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination.
    N Engl J Med. 2024;391:2327-2336.
    PubMed     Abstract available
    
    
    November 2024
25. YOSHIDA LM, Toizumi M, Nguyen HAT, Quilty BJ, et al
    Effect of a Reduced PCV10 Dose Schedule on Pneumococcal Carriage in Vietnam.
    N Engl J Med. 2024;391:1992-2002.
    PubMed     Abstract available
    
    
    
26. OLIVO-FREITES C, Miguez-Arosemena P, Olivo-Freites C, Edelman D, et al
    Susceptibility to Vaccine-Preventable Infections in Asylum Seekers.
    N Engl J Med. 2024;391:1959-1960.
    PubMed    
    
    
    October 2024
27. WALSH EE, Perez Marc G, Falsey AR, Jiang Q, et al
    RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.
    N Engl J Med. 2024;391:1459-1460.
    PubMed    
    
    
    September 2024
28. GALLAGHER KE, Lucinde R, Bottomley C, Kaniu M, et al
    Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial.
    N Engl J Med. 2024 Sep 26. doi: 10.1056/NEJMoa2314620.
    PubMed     Abstract available
    
    
    
29. WALENSKY RP, Baggett MV, Tran KM, Shepard JO, et al
    Case 27-2024: A 24-Year-Old Man with Pain and Dyspnea.
    N Engl J Med. 2024;391:845-852.
    PubMed    
    
    
    August 2024
30. NACHEGA JB, Mohr EL, Dashraath P, Mbala-Kingebeni P, et al
    Mpox in Pregnancy - Risks, Vertical Transmission, Prevention, and Treatment.
    N Engl J Med. 2024 Aug 28. doi: 10.1056/NEJMp2410045.
    PubMed    
    
    
    July 2024
31. SINHA MS, Parmet WE, Gonsalves GS
    Deja Vu All Over Again - Refusing to Learn the Lessons of Covid-19.
    N Engl J Med. 2024 Jul 24. doi: 10.1056/NEJMp2406427.
    PubMed    
    
    
    
32. ROSEN CJ
    Viral Variants, Vaccinations, and Long Covid - New Insights.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMe2407575.
    PubMed    
    
    
    
33. XIE Y, Choi T, Al-Aly Z
    Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMoa2403211.
    PubMed     Abstract available
    
    
    
34. SALMON DA, Orenstein WA, Plotkin SA, Chen RT, et al
    Funding Postauthorization Vaccine-Safety Science.
    N Engl J Med. 2024;391:102-105.
    PubMed    
    
    
    June 2024
35. 
    Are We Prepared for Bird Flu?: ITT Episode 32.
    N Engl J Med. 2024;390:e59.
    PubMed    
    
    
    May 2024
36. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed    
    
    
    
37. RUBIN EJ, Baden LR, Marrazzo J, Monto A, et al
    Audio Interview: The Current State of Avian Influenza.
    N Engl J Med. 2024 May 20. doi: 10.1056/NEJMe2406223.
    PubMed    
    
    
    
38. WANG JJ, Schonborn L, Warkentin TE, Chataway T, et al
    Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.
    N Engl J Med. 2024;390:1827-1829.
    PubMed    
    
    
    April 2024
39. HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
    Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
    N Engl J Med. 2024;390:1186-1195.
    PubMed     Abstract available
    
    
    March 2024
40. HSIAO A, Fireman B, Klein NP
    Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
    N Engl J Med. 2024;390:1156.
    PubMed    
    
    
    
41. WOO EJ, Hulse AN
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155-1156.
    PubMed    
    
    
    
42. HAVIARI S, Massonnaud CR, Dupont A
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155.
    PubMed    
    
    
    
43. RASMUSSEN SA, Jamieson DJ
    Maternal RSV Vaccine - Weighing Benefits and Risks.
    N Engl J Med. 2024;390:1050-1051.
    PubMed    
    
    
    
44. DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al
    RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
    N Engl J Med. 2024;390:1009-1021.
    PubMed     Abstract available
    
    
    February 2024
45. MONTO AS, Zambon M, Weir JP
    The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
    N Engl J Med. 2024 Feb 28. doi: 10.1056/NEJMp2314801.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.